Physician profile
Jared R Langerman
NPI 1376961946
$3,780.57
in general payments reported to CMS, 2019-2025
14 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,737 · 2020: $14.15 · 2021: $681 · 2022: $464 · 2023: $234 · 2024: $415 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $1,442.55 | 2019 | |
| Inspire Medical Systems, INC. | $964.86 | 2021-2023 | Inspire |
| Aerin Medical INC. | $332.31 | 2021-2024 | |
| Smith+Nephew, INC. | $281.10 | 2019-2025 | |
| Medtronic, INC. | $210.03 | 2023-2024 | Sinuva |
| Integra Lifesciences Corporation | $127.12 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Medical Device Business Services, INC. | $100.92 | 2022 | |
| Fisher & Paykel Healthcare INC | $82.50 | 2024-2025 | Fisher & Paykel Healthcare |
| Stryker Corporation | $77.74 | 2021-2024 | Fiagon Navigation Unit |
| Acclarent, INC | $68.00 | 2020-2022 | |
| Medtronic USA, INC. | $31.77 | 2019 | |
| Optinose US, INC. | $23.25 | 2025 | |
| Resmed Corp | $20.37 | 2023 | |
| Glaxosmithkline, LLC. | $18.05 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Langerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.